# Long Term Follow-Up for RGX-111

> **NCT06103487** · — · ENROLLING_BY_INVITATION · sponsor: **REGENXBIO Inc.** · enrollment: 21 (estimated)

## Conditions studied

- Mucopolysaccharidosis I

## Interventions

- **GENETIC:** No Intervention

## Key facts

- **NCT ID:** NCT06103487
- **Lead sponsor:** REGENXBIO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-07-24
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06103487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06103487, "Long Term Follow-Up for RGX-111". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06103487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*